NASDAQ:MDGL - Madrigal Pharmaceuticals, Inc.
$134.56
 $0.58
+0.43%
2:00PM EDT
2019-02-15
Madrigal Pharmaceuticals, Inc., formerly Synta Pharmaceuticals Corp., is a clinical-stage biopharmaceutical company. The Company focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and nonalcoholic steatohepatitis (NASH). The Company's lead product, MGL-3196, is a Phase II-ready once-daily, oral, liver-directed selective thyroid hormone receptor-b (THR-b) agonist for the treatment of NASH, and heterozygous and homozygous familial hypercholesterolemia (FH). Its product pipeline also includes MGL-3745, which is used in the treatment of NASH and FH. MGL-3196 has completed Phase I single and multiple dose trials in healthy volunteers. MGL-3196 is being developed for dyslipidemia/hypercholesterolemia to lower low-density lipoproteins cholesterol, triglyceride levels and lipoprotein(a). MGL-3196 also reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  MDGL     avg for
industry  
  avg for
sector  
42 stocks weight:  27. 15   0. 00   0. 00  
42 stocks rank:  3. 42 K 1. 86 K 1. 09 K
# analyst opinions:  9. 00   14. 92   14. 43  
mean recommendation:  2. 10   1. 91   1. 93  

quick ratio:  73. 55   5. 37   1. 81  
current ratio:  73. 67   5. 69   2. 19  

target price low:  124. 00   88. 97   117. 82  
target price avg:  124. 78   115. 19   141. 96  
target price high:  253. 44   143. 40   163. 16  
1-yr high:  313. 90   124. 30   142. 77  
last close:  133. 98   101. 85   127. 84  
50-day avg:  112. 45   98. 27   122. 46  
200-day avg:  189. 89   99. 72   122. 70  
1-yr low:  94. 77   78. 19   100. 16  
volume:  140. 32 K 2. 38 M 4. 64 M
50-day avg volume:  243. 23 K 3. 31 M 4. 94 M
200-day avg volume:  288. 46 K 3. 23 M 4. 28 M

1-day return:  13. 41 % 0. 22 % 0. 48 %
this week return:  15. 14 % 1. 77 % 2. 01 %
12-wk return:  18. 17 % 6. 56 % 3. 33 %
52-wk return:  -15. 71 % -2. 23 % 14. 35 %

enterprise value (EV):  1. 30 B 55. 17 B 104. 51 B
market cap:  2. 06 B 49. 01 B 96. 46 B
EBITDA:  -35. 01 M 4. 82 B 7. 18 B
enterprise multiple (EV/EBITDA):  -37. 21   -91. 79   2. 29  
total debt:  0. 00   13. 73 B 16. 57 B
net income (common):  -29. 78 M 2. 37 B 3. 58 B

shares outstanding:  15. 39 M 607. 99 M 1. 22 B
shares:  7. 20 M 605. 53 M 1. 15 B
shares short:  1. 62 M 11. 62 M 12. 55 M
shares short prior month:  1. 51 M 11. 95 M 13. 44 M
short ratio:  5. 27   4. 82   3. 10  
short % of float:  130. 93 % 6. 19 % 2. 82 %
total cash/share:  31. 74   12. 02   11. 46  
total cash:  488. 54 M 7. 41 B 7. 37 B
free cash flow:  -14. 59 M 95. 99 M 2. 04 B
operating cash flow:  -25. 19 M 164. 74 M 3. 04 B

book value:  31. 37   14. 43   28. 26  
price/book:  4. 27   -1. 57   -2. 97  
operating margins:  0. 00 % -458. 01 % -642. 83 %
EBITDA margins:  0. 00 % 13. 81 % 22. 47 %
profit margins:  0. 00 % 6. 57 % 9. 92 %
gross margins:  0. 00 % 49. 33 % 54. 53 %

1-yr max volatility:  144. 96 % --- ---
1-yr mean volatility:  0. 32 % 0. 01 % 0. 06 %

1-yr EPS:  -2. 11   3. 03   4. 09  
forward EPS:  -4. 68   4. 33   6. 99  
P/E:  -63. 47   6. 11   26. 91  
forward P/E:  -24. 86   8. 38   10. 48  
PE/G:  86. 76   0. 37   5. 61  
growth:  -0. 73 % 683. 72 % 104. 79 %
earnings high:  -0. 61   1. 27   1. 66  
earnings avg:  -0. 76   1. 01   1. 53  
earnings low:  -1. 07   0. 76   1. 40  
revenue high:  -0. 00   2. 86 B 11. 19 B
revenue avg:  -0. 00   2. 78 B 10. 84 B
revenue low:  -0. 00   2. 67 B 10. 64 B
return on assets:  -7. 95 % -3. 27 % 3. 81 %
return on equity:  -11. 09 % 107. 48 % 27. 82 %

beta (1yr vs S&P500):  1. 47   1. 21   0. 93  
sharpe (1yr):  0. 51   0. 06   0. 98  

held % insiders:  11. 42 % 6. 46 % 3. 21 %
held % institutions:  96. 59 % 79. 10 % 70. 01 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-14 : MDGL
.    + 9.464 =         9.464 :: INITIAL WEIGHT
.    + 74.86 =        84.324 :: inverse volume-to-price addition
.  + 218.763 =       303.088 :: spline projection addition
.  - 160.351 =       142.737 :: poor performance penalty
.    x 1.004 =       143.261 :: one-year gains+dividend factor
.    x 8.366 =      1198.582 :: 13 weeks' performance factor
.    x 1.492 =       1788.87 :: industry recommendation factor
.    x 2.063 =      3690.499 :: symbol recommendation factor
.    x 0.999 =      3687.564 :: return on assets factor
.    x 0.999 =      3683.476 :: return on equity factor
.    x 6.292 =     23175.733 :: current ratio factor
.    x 1.007 =     23334.902 :: quick ratio factor
.    x 1.091 =     25452.734 :: short ratio factor
.    x 2.043 =      51992.51 :: price-to-book factor
.    x 1.076 =     55921.795 :: 5-day avg > 50-day avg
.    x 1.346 =     75286.552 :: P/E weight
.    x 0.328 =     24667.931 :: PE/G factor
.    x 1.526 =     37653.101 :: beta factor
.     x 0.51 =     19214.844 :: sharpe factor
.    x 0.973 =     18690.421 :: target low factor
.    x 0.954 =     17822.205 :: target mean factor
.    x 1.094 =     19505.084 :: target high factor
.    x 1.066 =     20784.867 :: industry 12-weeks return
.    x 0.991 =     20594.733 :: "drift" penalty 3 days ago
.    x 0.891 =     18347.248 :: "drift" penalty 5 days ago
.    x 0.985 =     18067.471 :: overall "drift" factor
.    x 0.999 =      18051.28 :: largest single-day jump factor
.     x 1.01 =     18231.206 :: mean volatility factor
.    x 1.097 =     20001.139 :: 42-day mean volatility factor
.      x 1.0 =     20002.481 :: factor hist industry gain for week 06
.   cubeRoot =        27.145 :: reduced for readability
.                     27.145 :: FINAL WEIGHT for NASDAQ:MDGL


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org